Cyanvac Llc
Clinical trials sponsored by Cyanvac Llc, explained in plain language.
-
Sniff your shot? new nasal COVID vaccine enters testing
⭐️ VACCINE ⭐️ OngoingThis study is testing a new COVID-19 vaccine given as a single spray into the nose. Researchers want to see if it is safe and if it triggers a good immune response against the virus. The trial will include up to 400 healthy adults aged 18 to 80, some of whom have had prior COVID …
Phase: PHASE2 • Sponsor: CyanVac LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:34 UTC
-
Sniff, Don't shoot: new nasal COVID vaccine enters testing
⭐️ VACCINE ⭐️ OngoingThis study is testing a new COVID-19 vaccine given as a single spray in the nose. It will compare this nasal spray to the currently approved mRNA shot to see if it is as safe and effective at preventing symptomatic COVID-19. The trial will enroll about 434 healthy adults and foll…
Phase: PHASE2 • Sponsor: CyanVac LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
Sniffing out a better mumps shot? new nasal vaccines enter human testing
⭐️ VACCINE ⭐️ OngoingThis early-stage trial is testing two new mumps vaccines given as a nasal spray. The main goal is to see if they are safe and can trigger an immune response in healthy adults who were vaccinated as children. Up to 60 participants will receive one dose of either vaccine or a place…
Phase: PHASE1 • Sponsor: CyanVac LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 25, 2026 14:08 UTC